Nonmelanoma skin cancer and the risk of second primary cancers: a systematic review
- PMID: 20570907
- PMCID: PMC2901413
- DOI: 10.1158/1055-9965.EPI-10-0243
Nonmelanoma skin cancer and the risk of second primary cancers: a systematic review
Abstract
Background: Based on empirical evidence, a personal history of nonmelanoma skin cancer (NMSC) has been hypothesized to be a risk factor for other cancers. Others hypothesize that NMSC may be a marker of high cutaneous vitamin D synthesis and therefore inversely associated with risk of other malignancies. To reconcile these divergent views, we carried out a systematic review to determine the association between NMSC and subsequent risk of other cancers.
Methods: Bibliographic databases were searched through March 2009. Studies were included if sufficient information was presented to estimate the risk of developing other cancers following NMSC. Studies were reviewed and data were abstracted independently in duplicate with disagreements resolved by consensus.
Results: Of the 21 included studies, 15 reported the association between NMSC and risk of all other cancers combined. NMSC was significantly associated with increased risk of another malignancy among cohort studies based on cancer registries summary random-effects relative risk (SRR), 1.12; 95% confidence interval (CI), 1.07-1.17; n = 12 studies) and those with individual-level data (SRR, 1.49; 95% CI, 1.12-1.98; n = 3). In stratified analyses of registry studies, this association held true for both squamous (SRR, 1.17; 95% CI, 1.12-1.23; n = 7) and basal cell carcinoma (SRR, 1.09; 95% CI, 1.01-1.17; n = 7), and both men (SRR, 1.14; 95% CI, 1.09-1.20; n = 12) and women (SRR, 1.10; 95% CI, 1.04-1.15; n = 12).
Conclusions: Strong, consistent evidence indicates that a personal history of NMSC is associated with increased risk of developing other malignancies.
Impact: For unknown reasons, NMSC may be a risk factor for other cancers.
Figures


Similar articles
-
Nonmelanoma skin cancer and risk of all-cause and cancer-related mortality: a systematic review.Arch Dermatol Res. 2017 May;309(4):243-251. doi: 10.1007/s00403-017-1724-5. Epub 2017 Mar 11. Arch Dermatol Res. 2017. PMID: 28285366 Free PMC article.
-
Sun protection for preventing basal cell and squamous cell skin cancers.Cochrane Database Syst Rev. 2016 Jul 25;7(7):CD011161. doi: 10.1002/14651858.CD011161.pub2. Cochrane Database Syst Rev. 2016. PMID: 27455163 Free PMC article.
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2020 Jan 9;1:CD011535. doi: 10.1002/14651858.CD011535.pub3. PMID: 29271481 Free PMC article. Updated.
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4. Cochrane Database Syst Rev. 2021. Update in: Cochrane Database Syst Rev. 2022 May 23;5:CD011535. doi: 10.1002/14651858.CD011535.pub5. PMID: 33871055 Free PMC article. Updated.
-
St Andrews Referral Delay in Skin Cancer (StARDISC): a study of keratinocyte skin cancer time to treatment, growth, invasiveness, British Association of Dermatologists risk factors and excision adequacy.Br J Dermatol. 2025 Jun 20;193(1):157-166. doi: 10.1093/bjd/ljaf097. Br J Dermatol. 2025. PMID: 40080699
Cited by
-
Risk of Non-cutaneous Cancers in Individuals with Basal Cell Carcinoma: A Population-based Cohort Study.Acta Derm Venereol. 2022 Nov 30;102:adv00826. doi: 10.2340/actadv.v102.4451. Acta Derm Venereol. 2022. PMID: 36448850 Free PMC article.
-
Sunburn and sun-protective behaviors among adults with and without previous nonmelanoma skin cancer (NMSC): A population-based study.J Am Acad Dermatol. 2016 Aug;75(2):371-379.e5. doi: 10.1016/j.jaad.2016.02.1236. Epub 2016 May 16. J Am Acad Dermatol. 2016. PMID: 27198078 Free PMC article.
-
Indications for Digital Monitoring of Patients With Multiple Nevi: Recommendations from the International Dermoscopy Society.Dermatol Pract Concept. 2022 Oct 1;12(4):e2022182. doi: 10.5826/dpc.1204a182. eCollection 2022 Nov. Dermatol Pract Concept. 2022. PMID: 36534527 Free PMC article.
-
Evaluating the trend of cutaneous malignant tumors in Ilam from 2002 to 2011.J Family Med Prim Care. 2019 Feb;8(2):717-721. doi: 10.4103/jfmpc.jfmpc_178_17. J Family Med Prim Care. 2019. PMID: 30984701 Free PMC article.
-
Interventions After First Post-Transplant Cutaneous Squamous Cell Carcinoma: A Proposed Decision Framework.Transpl Int. 2022 Nov 22;35:10880. doi: 10.3389/ti.2022.10880. eCollection 2022. Transpl Int. 2022. PMID: 36484063 Free PMC article. Review.
References
-
- American Cancer Society . Cancer Facts & Figures 2009. American Cancer Society; Atlanta: 2009.
-
- Rogers HW, Weinstock MA, Harris AR, et al. Incidence estimate of nonmelanoma skin cancer in the United States, 2006. Arch Dermatol. 2010;146:283–7. - PubMed
-
- de Vries E, van de Poll-Franse LV, Louwman WJ, de Gruijl FR, Coebergh JW. Predictions of skin cancer incidence in the Netherlands up to 2015. Br J Dermatol. 2005;152:481–8. - PubMed
-
- Chen JG, Fleischer AB, Jr, Smith ED, et al. Cost of nonmelanoma skin cancer treatment in the United States. Dermatol Surg. 2001;27:1035–8. - PubMed
-
- Marcil I, Stern R. Risk of developing a subsequent nonmelanoma skin cancer in patients with a history of nonmelanoma skin cancer. Arch Dermatol. 2000;136:1524–30. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical